Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-29 extended-release capsules for papulopustular rosacea
2016-003197-41Phase 2Terminated
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline hydrochloride modified release (DFD-29) in papulopustular rosacea, sponsored by Dr. Reddy's Laboratories. Started Oct 2016; status: terminated.
02
Drugs
minocycline hydrochloride modified release (DFD-29)
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2016-003197-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003197-41.